Wegovy Pill Offers Needle-Free Weight Loss

A pill version of the popular GLP-1 weight loss medication Wegovy has been released, providing an alternative to the widely used injection. This oral form, also containing semaglutide, mimics the body's satiety hormones to signal fullness.

While the pill requires a higher milligram dose due to lower absorption rates in the stomach, studies suggest its weight loss effectiveness is comparable to the injectable form. Clinical trials indicate a slight difference in average body weight reduction between the two over extended periods.

Common side effects for both the pill and injection include gastrointestinal issues like nausea and vomiting. A key difference in convenience lies in their administration: the injection is weekly, while the pill must be taken daily on an empty stomach, followed by a 30-minute waiting period before eating or drinking.

Financially, the Wegovy pill is currently less expensive than the injection for out-of-pocket payers, potentially saving between $50 to $150 monthly. The availability of oral GLP-1 options is expected to expand in the coming years with other manufacturers nearing approval for similar medications.